Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1982 Jan;13(1):73–79. doi: 10.1111/j.1365-2125.1982.tb01340.x

Prognosis of treated hypertension 1951-1981.

C J Bulpitt
PMCID: PMC1401775  PMID: 7066157

Abstract

1 The 5 year survival of hypertensive patients in several studies was reviewed to demonstrate the adverse effects of increasing age, being male, having a higher untreated blood pressure of severe retinal changes. 2 The decrease in survival with increase in diastolic blood pressure was not linear, mortality being relatively constant below 90 mmHg. 3 The adverse effect of severe retinal changes was independent of the untreated blood pressure. 4 In patients selected with mild hypertension, 5 year survival can exceed 97% even when untreated. 5 Owing to the lack of suitable data we cannot conclude that treatment was more effective in prolonging life in the 1970s than in previous decades. 6 In the United States non-white patients with hypertension fared worse than white patients. 7 The serum cholesterol was not positively related to mortality in treated hypertension patients. 8 Treated hypertensive patients who smoked had at least a two-fold increase in mortality over those who did not. 9 Treated patients under the age of 50 years had a four-fold increase in mortality compared with the general population. This was greater than any excess mortality observed in the elderly.

Full text

PDF
73

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amery A., Berthaux P., Birkenhäger W., Boel A., Brixko P., Bulpitt C., Clement D., De Padua F., Deruyttere M., De Schaepdryver A. Antihypertensive therapy in patients above age 60 years (Fourth Interim report of the European Working Party on High Blood pressure in Elderly: EWPHE). Clin Sci Mol Med Suppl. 1978 Dec;4:263s–270s. doi: 10.1042/cs055263s. [DOI] [PubMed] [Google Scholar]
  2. Breslin D. J., Gifford R. W., Jr, Fairbairn J. F., 2nd, Kearns T. P. Prognostic importance of ophthalmoscopic findings in essential hypertension. JAMA. 1966 Jan 31;195(5):335–338. [PubMed] [Google Scholar]
  3. Bulpitt C. J., Beilin L. J., Clifton P., Coles E. C., Dollery C. T., Gear J. S., Harper G. S., Johnson B. F., Munro-Faure A. D. Risk factors for death in treated hypertensive patients. Report from the D.H.S.S. Hypertension Care Computing Project. Lancet. 1979 Jul 21;2(8134):134–137. doi: 10.1016/s0140-6736(79)90013-8. [DOI] [PubMed] [Google Scholar]
  4. FRANT R., GROEN J. Prognosis of vascular hypertension; a 9 year follow-up study of 418 cases. Arch Intern Med (Chic) 1950 May;85(5):727–750. doi: 10.1001/archinte.1950.00230110002001. [DOI] [PubMed] [Google Scholar]
  5. Fry J. Natural history of hypertension. A case for selective non-treatment. Lancet. 1974 Aug 24;2(7878):431–433. doi: 10.1016/s0140-6736(74)91816-9. [DOI] [PubMed] [Google Scholar]
  6. HARINGTON M., KINCAID-SMITH P., McMICHAEL J. Results of treatment in malignant hypertension: a seven-year experience in 94 cases. Br Med J. 1959 Nov 14;2(5158):969–980. doi: 10.1136/bmj.2.5158.969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Helgeland A. Treatment of mild hypertension: a five year controlled drug trial. The Oslo study. Am J Med. 1980 Nov;69(5):725–732. doi: 10.1016/0002-9343(80)90438-6. [DOI] [PubMed] [Google Scholar]
  8. Holme I., Waaler H. T. Five-year mortality in the city of Bergen, Norway, according to age, sex and blood pressure. Acta Med Scand. 1976;200(3):229–239. doi: 10.1111/j.0954-6820.1976.tb08224.x. [DOI] [PubMed] [Google Scholar]
  9. KINCAID-SMITH P., McMICHAEL J., MURPHY E. A. The clinical course and pathology of hypertension with papilloedema (malignant hypertension). Q J Med. 1958 Jan;27(105):117–153. [PubMed] [Google Scholar]
  10. Miall W. E., Chinn S. Screening for hypertension: some epidemiological observations. Br Med J. 1974 Sep 7;3(5931):595–600. doi: 10.1136/bmj.3.5931.595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. NEWMAN M. J., ROBERTSON J. I. Some aspects of prognosis in treated hypertension. Br Med J. 1959 May 30;1(5134):1368–1373. doi: 10.1136/bmj.1.5134.1368. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. SCHOTTSTAEDT M. F., SOKOLOW M. The natural history and course of hypertension with papilledema (malignant hypertension). Am Heart J. 1953 Mar;45(3):331–362. doi: 10.1016/0002-8703(53)90147-1. [DOI] [PubMed] [Google Scholar]
  13. SMIRK F. H., VEALE A. M., ALSTAD K. S. Basal and supplemental blood pressures in relationship to life expectancy and hypertension symptomatology. N Z Med J. 1959 Dec;58:711–735. [PubMed] [Google Scholar]
  14. Trafford J. A., Horn C. R., O'Neal H., McGonigle R., Halford-Maw L., Evans R. Five year follow-up of effects of treatment of mild and moderate hypertension. Br Med J (Clin Res Ed) 1981 Apr 4;282(6270):1111–1113. doi: 10.1136/bmj.282.6270.1111. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES